Eikon Therapeutics Common Stock Overview
Eikon Therapeutics Common Stock Discounted Cash Flow
DCF Analysis for EIKN.
Get informed when a big investor buys or sells
+ FollowFair Value
$-2.82
Current Fair Value
$-2.82
↓ 132.2% Downside
Overvalued by 132.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison